Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV)

被引：0
|
作者：
McCombs, Jeffrey S.
Shin, Janet
Hines, Patricia
Saab, Sammy
Yuan, Yong
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S936 / S936
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD EVALUATION OF THE ECONOMIC IMPACT OF DURATION OF DRUG THERAPY IN THE TREATMENT OF HEPATITIS C VIRUS (HCV)
    McCombs, J.
    Shin, J.
    Hines, P.
    Saab, S.
    Yuan, Y.
    VALUE IN HEALTH, 2011, 14 (03) : A121 - A121
  • [2] Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV): an Update
    McCombs, Jeffrey S.
    Shin, Janet
    Hines, Patricia
    Saab, Sammy
    Yuan, Yong
    GASTROENTEROLOGY, 2012, 142 (05) : S1011 - S1011
  • [3] LOW TREATMENT RATES AND SUBOPTIMAL TREATMENT COMPLETION RATES TO HEPATITIS C VIRUS (HCV) THERAPY: A REAL-WORLD ANALYSIS OF A LARGE US COHORT
    Brooks, L. H., Jr.
    Schwebke, K.
    Livornese, R.
    Van Caster, K.
    Nguyen, M. H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S363 - S363
  • [4] Low Treatment Rates and Suboptimal Treatment Completion Rates to Hepatitis C Virus (HCV) Therapy: A Real-World Analysis of a Large US Cohort
    Vutien, Philip
    Kim, Yoona
    Brooks, Louis
    Livornese, Richard
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2014, 146 (05) : S920 - S920
  • [5] Real-world performance of the NeuMoDx TM HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA
    Luebke, Nadine
    Walker, Andreas
    Obermeier, Martin
    Camdereli, Jennifer
    Paluschinski, Martha
    Walotka, Lara
    Schupp, Anna-Kathrin
    Tometten, Inga
    Hauka, Sandra
    Heger, Eva
    Timm, Joerg
    JOURNAL OF VIROLOGICAL METHODS, 2024, 327
  • [6] Hepatitis C (HCV) Treatment and SVR: The Gap Between Clinical Trials and the Real-World
    Tahir, Madiha
    Alvi, Fatima
    Alam, Imtiaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S125 - S125
  • [7] Commentary: real-world triple therapy experience treating hepatitis C virus
    Heron, T.
    Miller, M. H.
    Dillon, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (05) : 542 - 542
  • [8] Impact of Drug Therapy Duration in Patients With Hepatitis C
    McCombs, Jeffrey S.
    Shin, Janet
    Hines, Patricia
    Saab, Sammy
    Yuan, Yong
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2012, 4 : SP19 - SP27
  • [9] Hepatitis C Virus Treatment in the 'Real-World': How Well Do 'Real' Patients Respond?
    Friedman, N. Deborah
    Green, Joanne H.
    Weber, Hanna M.
    Stephen, Shiny
    Lane, Stephen E.
    Ting, Alvin Y.
    Watson, Jonathan P.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2014, 4 (03) : 214 - 220
  • [10] Drug transporters as factors for hepatitis C virus (HCV) therapy
    Han, Yong-Hae
    DRUG METABOLISM REVIEWS, 2011, 43 : 9 - 9
12345